Stigmabase is a non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

2020년 9월 18일 금요일

South Korea approves Phase 2/3 trials of Celltrion's COVID-19 antibody drug

 South Korea said on Thursday it has approved Celltrion Inc's experimental COVID-19 treatment for Phase 2/3 clinical trials, as the ...


View article...